The mTOR homeostatic window in kidney disease
Introduction Mechanistic target of rapamycin (mTOR) signaling is both essential for renal cellular homeostasis and a driver of pathological remodeling when persistently activated. This paradox is especially evident in podocytes, where excessive mTOR complex 1 (mTORC1) activity promotes hypertrophy, metabolic stress, proteinuria, and fibrosis, whereas excessive suppression can destabilize the filtration barrier. Methods We review cell- and context-specific functions of mTORC1 and mTOR complex 2 (mTORC2) across kidney disease, including podocytopathies, chronic kidney disease, acute kidney injury-to-chronic kidney disease transition, and transplantation. Results We propose that the therapeutic objective should shift from global mTOR inhibition toward precision modulation defined by cell identity, molecular complex, dose, disease stage, and duration. Podocyte-targeted everolimus delivery provides preclinical support that spatial restriction can reshape pathway effects and raises the hypothesis that it could widen the therapeutic window. Discussion This homeostatic window theory may guide safer antifibrotic and glomerular therapies.
Authors
- Kui Fan
- Li Zeng (ORCID: https://orcid.org/0000-0002-5016-6557)
- Lanxing Zhou
- Maozhi Tang
- Yuan Yu
- Qin Zhou
Institutions
- Chongqing University (CN)
- Second Affiliated Hospital of Chongqing Medical University (CN)
- Chongqing Emergency Medical Center (CN)
Publication Details
- Journal
- Frontiers in Nephrology
- Published
- 2026-11-18
- DOI
- https://doi.org/10.3389/fneph.2026.2008149
- Primary Topic
- Renal Diseases and Glomerulopathies
- Type
- article
- Field-Weighted Citation Impact
- 0.00